2-Thiophenecarboxamide, 3-[[2-[[1-[2-(dimethylamino)acetyl]-1,2,3,4-tetrahydro-6-methoxy-4,4-dimethyl-7-quinolinyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]- manufacturers
- GSK2163632A
-
- $3100.00
-
2026-07-27
- CAS:1123163-20-1
- Purity:
- Supply Ability: 10g
|
| | 2-Thiophenecarboxamide, 3-[[2-[[1-[2-(dimethylamino)acetyl]-1,2,3,4-tetrahydro-6-methoxy-4,4-dimethyl-7-quinolinyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]- Basic information |
| Product Name: | 2-Thiophenecarboxamide, 3-[[2-[[1-[2-(dimethylamino)acetyl]-1,2,3,4-tetrahydro-6-methoxy-4,4-dimethyl-7-quinolinyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]- | | Synonyms: | 2-Thiophenecarboxamide, 3-[[2-[[1-[2-(dimethylamino)acetyl]-1,2,3,4-tetrahydro-6-methoxy-4,4-dimethyl-7-quinolinyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-;GSK2163632A;GSK-2163632A,GSK2163632A | | CAS: | 1123163-20-1 | | MF: | C27H32N8O3S | | MW: | 548.66 | | EINECS: | | | Product Categories: | | | Mol File: | 1123163-20-1.mol | ![2-Thiophenecarboxamide, 3-[[2-[[1-[2-(dimethylamino)acetyl]-1,2,3,4-tetrahydro-6-methoxy-4,4-dimethyl-7-quinolinyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]- Structure](CAS/20210305/GIF/1123163-20-1.gif) |
| | 2-Thiophenecarboxamide, 3-[[2-[[1-[2-(dimethylamino)acetyl]-1,2,3,4-tetrahydro-6-methoxy-4,4-dimethyl-7-quinolinyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]- Chemical Properties |
| density | 1.370±0.06 g/cm3(Predicted) | | pka | 13.47±0.50(Predicted) |
| | 2-Thiophenecarboxamide, 3-[[2-[[1-[2-(dimethylamino)acetyl]-1,2,3,4-tetrahydro-6-methoxy-4,4-dimethyl-7-quinolinyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]- Usage And Synthesis |
| Description | GSK2163632A is an insulin-like growth factor 1 receptor inhibitor. It acts by binding to a novel region of the GRK active site cleft that could likely be exploited to achieve more selectivity. | | Uses | GSK2163632A is a selective G protein-coupled receptor kinase (GRK) inhibitor that can be used as a probe for studying heart failure and Parkinson's disease. GSK2163632A potently inhibits GRK1 and GRK5, and also inhibits Rho-associated coiled-coil kinase (ROCK) and insulin-like growth factor receptor IGF-1R. GSK2163632A binds to GRK2 in a manner similar to Paroxetine (HY-122272). | | References | [1] Identification and StructureFunction Analysis of Subfamily Selective G Protein-Coupled Receptor Kinase Inhibitors |
| | 2-Thiophenecarboxamide, 3-[[2-[[1-[2-(dimethylamino)acetyl]-1,2,3,4-tetrahydro-6-methoxy-4,4-dimethyl-7-quinolinyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]- Preparation Products And Raw materials |
|
|
Tag:2-Thiophenecarboxamide, 3-[[2-[[1-[2-(dimethylamino)acetyl]-1,2,3,4-tetrahydro-6-methoxy-4,4-dimethyl-7-quinolinyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-(1123163-20-1)
Related Product Information
|